RxDoctor Payments Data

Bertin Chevis, MD

Family Medicine · Bay St Louis, MSNPI 1649228529

Payments from drug & device makers

$720in general payments, 2019–2025

Across 38 payments — averaging $18.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$281
  • Astellas Pharma US Inc$95
  • GSK$90
  • Esperion Therapeutics, Inc.$55
  • AbbVie$43
  • Bayer$33
  • plus $122 from 7 others

What the payments were for

  • Food & beverage$59583%
  • Education$12517%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$720 in reported general payments places this provider in the 50th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$79,999
Medicare patients
231
Services billed
1,385

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter108$108,867
JardianceEmpagliflozin71$93,767
EliquisApixaban97$60,595
Breztri AerosphereBudesonide/Glycopyr/Formoterol47$40,744
FarxigaDapagliflozin Propanediol44$40,670
JanuviaSitagliptin Phosphate37$38,828
OzempicSemaglutide30$28,368
XareltoRivaroxaban32$17,018
LinzessLinaclotide15$16,359
Breo ElliptaFluticasone/Vilanterol19$12,920
NexlizetBempedoic Acid/Ezetimibe14$12,566
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog13$7,246
MyrbetriqMirabegron14$7,002
SymbicortBudesonide/Formoterol Fumarate14$5,766
Lantus SolostarInsulin Glargine,hum.Rec.Anlog38$4,101

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta$90$121,787127 claims
AstraZenecaBreztri Aerosphere, Farxiga, Symbicort$281$87,180105 claims
AbbVieLinzess, Synthroid$43$18,52333 claims
Esperion Therapeutics, Inc.Nexlizet$55$12,56614 claims
Astellas Pharma US IncMyrbetriq$95$7,00214 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Bay St Louis

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →